Recombinant Marinomonas sp. Elongation factor Tu (tuf)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the in-stock format preferentially. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specific delivery times. All proteins are shipped with blue ice packs by default. Request dry ice in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
tuf; Mmwyl1_4278Elongation factor Tu; EF-Tu
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-407
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Marinomonas sp. (strain MWYL1)
Target Names
tuf
Target Protein Sequence
MAKSKFERNK PHVNVGTIGH VDHGKTTLTA ALTRVCAEVF GGTAVAFDGI DNAPEERERG ITISTSHVEY DSPTRHYAHV DCPGHADYVK NMITGAAQMD GAILVCGATD GPMPQTREHI LLSRQVGVPY IVVFLNKSDL LADDCGGADS EEYAEMLELV EMELRDLLSE YDFPGDDTPI IPGSALMALK GEDDNEMGTT AVRKLVETLD TYIPDPERAI DGAFLMPIED VFSIQGRGTV VTGRVERGII KIQEEVEIVG IVDTTKTTCT GVEMFRKLLD EGRAGENCGI LLRGTKREDV QRGQVLAKPG SITPHTQFEA EVYVLGKDEG GRHTPFFKGY RPQFYFRTTD VTGACSLPEG VEMVMPGDNI QMTVELIHPI AMDEGLRFAI REGGRTVGAG VVAKILK
Uniprot No.

Target Background

Function
This protein facilitates the GTP-dependent binding of aminoacyl-tRNA to the ribosomal A-site during protein biosynthesis.
Database Links
Protein Families
TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, EF-Tu/EF-1A subfamily
Subcellular Location
Cytoplasm.

Q&A

Experimental Design for Studying Recombinant Marinomonas sp. Elongation Factor Tu (tuf)

Q: How should I design experiments to study the recombinant Marinomonas sp. Elongation Factor Tu (tuf) in terms of its role in protein synthesis and potential moonlighting functions?

A:

  • Objective: Investigate the canonical role of EF-Tu in protein synthesis and its potential moonlighting functions.

  • Methods:

    • Protein Synthesis Assays: Use in vitro translation assays to assess EF-Tu's ability to facilitate aminoacyl-tRNA binding to ribosomes.

    • Moonlighting Functions: Investigate interactions with cell surface receptors or extracellular matrix components using co-immunoprecipitation or surface plasmon resonance.

    • Cellular Localization: Employ fluorescence microscopy to track EF-Tu's localization within and on the surface of cells.

Data Analysis and Contradiction Resolution

Q: How can I resolve contradictions in data regarding the expression levels of recombinant Marinomonas sp. EF-Tu in different experimental conditions?

A:

  • Approach:

    • Replication: Ensure that experiments are replicated multiple times to confirm findings.

    • Normalization: Normalize expression data using appropriate controls (e.g., housekeeping genes) to account for variability.

    • Statistical Analysis: Use statistical methods (e.g., ANOVA) to identify significant differences between conditions.

    • Literature Review: Consult existing literature to contextualize findings and resolve discrepancies.

Advanced Research Questions

Q: What advanced techniques can be employed to study the structural dynamics of recombinant Marinomonas sp. EF-Tu and its interactions with other cellular components?

A:

  • Techniques:

    • Structural Biology: Use X-ray crystallography or NMR spectroscopy to determine the three-dimensional structure of EF-Tu.

    • Molecular Dynamics Simulations: Perform simulations to predict dynamic interactions with ribosomes or other proteins.

    • Biochemical Assays: Conduct pull-down assays or gel filtration to study protein-protein interactions.

Methodological Considerations for Expression and Purification

Q: What methodological considerations are crucial for the efficient expression and purification of recombinant Marinomonas sp. EF-Tu?

A:

  • Expression Systems: Choose an appropriate host organism (e.g., E. coli) and optimize growth conditions for high yield.

  • Purification Protocols: Employ affinity chromatography (e.g., His-tag) followed by size exclusion chromatography for purity.

  • Buffer Conditions: Optimize buffer pH, salt concentration, and additives to maintain protein stability during purification.

Integration with Microbiome Research

Q: How can studies on recombinant Marinomonas sp. EF-Tu inform or be integrated with broader microbiome research?

A:

  • Microbiome Context: Investigate how EF-Tu's moonlighting functions might influence bacterial interactions within microbiomes.

  • High-Throughput Sequencing: Use techniques like metagenomics to study EF-Tu's role in environmental or host-associated microbiomes.

  • Bioinformatics Tools: Apply tools like Qiita for sequence analysis to understand EF-Tu's impact on microbial community dynamics.

Translational Applications

Q: What potential translational applications exist for research on recombinant Marinomonas sp. EF-Tu, particularly in biotechnology or medicine?

A:

  • Biotechnology: Explore EF-Tu's use in improving protein expression systems or as a therapeutic target.

  • Medicine: Investigate EF-Tu as a potential antigen for vaccine development or as a target for antimicrobial therapies.

  • Environmental Applications: Consider EF-Tu's role in bioremediation processes, given Marinomonas species' involvement in environmental degradation.

Challenges in Studying Recombinant Proteins

Q: What are common challenges faced when studying recombinant proteins like Marinomonas sp. EF-Tu, and how can they be addressed?

A:

  • Challenges:

    • Protein Stability: Recombinant proteins may be unstable or prone to aggregation.

    • Expression Levels: Low expression can hinder purification and functional studies.

  • Solutions:

    • Optimize Expression Conditions: Adjust temperature, media composition, and induction strategies.

    • Protein Engineering: Modify the protein sequence to enhance stability or solubility.

    • Purification Strategies: Employ gentle purification protocols to maintain protein integrity.

Collaborative Research Opportunities

Q: How can researchers collaborate effectively across disciplines to advance our understanding of recombinant Marinomonas sp. EF-Tu?

A:

  • Interdisciplinary Teams: Form teams with structural biologists, microbiologists, and bioinformaticians.

  • Data Sharing: Utilize open databases and collaborative platforms for data sharing and analysis.

  • Workshops and Conferences: Participate in workshops to discuss methodologies and share findings.

Ethical Considerations in Research

Q: What ethical considerations should researchers keep in mind when conducting studies involving recombinant Marinomonas sp. EF-Tu?

A:

  • Biosafety: Ensure compliance with biosafety guidelines when handling recombinant organisms.

  • Data Integrity: Maintain transparency and integrity in data collection and reporting.

  • Environmental Impact: Assess potential environmental impacts of releasing genetically modified organisms.

Future Directions

Q: What future research directions hold the most promise for advancing our understanding and application of recombinant Marinomonas sp. EF-Tu?

A:

  • Single-Molecule Studies: Employ techniques like single-particle tracking to study EF-Tu dynamics at the molecular level.

  • Synthetic Biology: Design synthetic systems incorporating EF-Tu for novel biotechnological applications.

  • Systems Biology Approaches: Use systems biology to model and predict EF-Tu's role in complex biological networks.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.